XtalPi uses artificial intelligence, cloud computing and quantum physics to improve drug design processes. Photo: MintBeijing: Alphabet Inc.’s Google, Tencent Holdings Ltd and Sequoia Capital China have joined a $15 million B series funding round for Boston- and Shenzhen-based artificial intelligence (AI) pharmaceutical firm XtalPi Inc.Sequoia led the round, which brings the startup’s total funding amount to $20 million, XtalPi and Google said in statements on Wednesday. XtalPi uses AI, cloud computing and quantum physics to improve drug design processes. Google has recently ramped up investment in the Chinese market where its search engine remains blocked. Last month it announced it had launched a dedicated AI lab in the country.

Source: Mint January 24, 2018 09:11 UTC